XOMA to Announce Second Quarter 2011 Financial Results and Host Webcast Conference Call on August 4 Jul 28, 2011 8:00am EDT
XOMA Announces Phase 2a Six-Month Top Line Trial Results Support Safety and Biological Activity Jun 08, 2011 4:15pm EDT
XOMA Announces Presentation and Webcast at Jefferies 2011 Global Healthcare Conference Jun 03, 2011 8:00am EDT
XOMA 3AB, a Novel Triple-Antibody Anti-Botulinum Neurotoxin Product, Enters Phase 1 Clinical Testing May 03, 2011 8:46am EDT
XOMA to Announce First Quarter 2011 Financial Results and Host Webcast Conference Call on May 5 May 03, 2011 7:00am EDT
XOMA Announces Presentation and Webcast at BioCentury Future Leaders Conference Apr 11, 2011 8:00am EDT
